75F40122F19002↗

Name: 75F40122F19002: Understanding the Prevalence, Experiences, Knowledge, and Perceptions of Falsified and Unapproved Pharmaceuticals in an Enriched Population Being Assessed for or Entering Substance Use Disorder Treatment
Creator: SpendQuery

UNDERSTANDING THE PREVALENCE, EXPERIENCES, KNOWLEDGE, AND PERCEPTIONS OF FALSIFIED AND UNAPPROVED PHARMACEUTICALS IN AN ENRICHED POPULATION BEING ASSESSED FOR OR ENTERING SUBSTANCE USE DISORDER TREATMENT

Delivery Order · Food and Drug Administration · to Integrated Behavioral Health, Inc. (UEI L9YZF5SG6WN1) · data as of 2026-09-30

Obligated to date$561.0K4 actions

Current value$1.05Mwith options exercised

Period2022-09-16 → 2027-09-28current end date

Up for re-bid: ends 2027-09-28. Recompete brief →

What it is

Product or service: Special Studies/Analysis- Scientific Data (PSC B529)
Industry: Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) (NAICS 541715)
Contracting office: Fda Office of Acq Grant Svcs (75F401)
Competition: Full and open competition · 1 offer received
Pricing: Firm fixed price
How it was bought: Multiple-award IDIQ · under 75F40121D00032
Where the work is: Montgomery, MD · district MD-08
Topics: opioids

Obligations by fiscal year

FY2023$0

FY2024$166.0K

FY2025$175.1K

FY2026$219.9K

SpendQuery holds FY2023 on; earlier years are on USAspending.gov.

Subcontractors: where the money went next

No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.

Every action

4 actions since 2023-08-02. Each is a modification or amendment with the money it added or took back.

Date	Modification	Kind	Amount	What the agency wrote
2026-03-24	P00004	Option exercised	$219.9K	UNDERSTANDING THE PREVALENCE, EXPERIENCES, KNOWLEDGE, AND PERCEPTIONS OF FALSIFIED AND UNAPPROVED PHARMACEUTICALS IN AN ENRICHED POPULATION BEING ASSESSED FOR OR ENTERING SUBSTANCE USE DISORDER TREATMENT
2025-04-29	P00003	Option exercised	$175.1K	UNDERSTANDING THE PREVALENCE, EXPERIENCES, KNOWLEDGE, AND PERCEPTIONS OF FALSIFIED AND UNAPPROVED PHARMACEUTICALS IN AN ENRICHED POPULATION BEING ASSESSED FOR OR ENTERING SUBSTANCE USE DISORDER TREATMENT
2024-03-25	P00002	Option exercised	$166.0K	UNDERSTANDING THE PREVALENCE, EXPERIENCES, KNOWLEDGE, AND PERCEPTIONS OF FALSIFIED AND UNAPPROVED PHARMACEUTICALS IN AN ENRICHED POPULATION BEING ASSESSED FOR OR ENTERING SUBSTANCE USE DISORDER TREATMENT
2023-08-02	P00001	Administrative change	$0	UNDERSTANDING THE PREVALENCE, EXPERIENCES, KNOWLEDGE, AND PERCEPTIONS OF FALSIFIED AND UNAPPROVED PHARMACEUTICALS IN AN ENRICHED POPULATION BEING ASSESSED FOR OR ENTERING SUBSTANCE USE DISORDER TREATMENT

Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-09-30). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗